In response to the growing cardiometabolic safety concerns about the use of atypical antipsychotic (AAP) medications in children,1,2 several state Medicaid agencies have adopted a novel, more clinically nuanced and individualized approach to reviewing the appropriateness of AAP use, namely, peer review prior authorization (PA) policies.3 Physicians must receive preapproval through contracted clinicians (peer reviewers) to prescribe AAPs to certain-aged children. We assessed the effect of peer review PA policies on AAP use among Medicaid-insured youth according to age restriction criteria.
Zito JM, Burcu M, McKean S, Warnock R, Kelman J. Pediatric Use of Antipsychotic Medications Before and After Medicaid Peer Review Implementation. JAMA Psychiatry. 2018;75(1):100–103. doi:10.1001/jamapsychiatry.2017.3493
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: